Tom Fleming

last updated 10/20/2017

Tom Fleming

Vice President and General Manager at Boston Scientific Corporation

Location:
300 Boston Scientific Way, Marlborough, Massachusetts, United States
HQ Phone:
(508) 683-4000

General Information

Affiliations

Board Member - FEops nv

Recent News  

FEops Elects Tom Fleming to Its Board of Directors

FEops Elects Tom Fleming to Its Board of Directors
Cardiovascular device veteran says FEops' predictive R&D and procedure-planning platform, FEops HEARTguide™, is "pivotal" to facilitating enduring success for transcatheter-based device therapies February 15, 2018 09:44 AM Eastern Standard Time GENT, Belgium--(BUSINESS WIRE)--FEops, a leader in personalized computational modeling and simulation for structural heart interventions, today announced that it has elected Tom Fleming to its board of directors, effective immediately. In his most recent role, Fleming served for over five years as Vice President and General Manager for Boston Scientific Corporation in the Structural Heart Valve business . He has been active in the cardiovascular device market for more than two decades. "The addition of an industry veteran with the stature of Tom Fleming to our board further substantiates the extraordinary opportunity for FEops to become a primary catalyst in the way novel transcatheter-based structural heart solutions are being developed and interventional cardiovascular procedures are preoperatively planned," said Dr.Matthieu De Beule , FEops CEO and Founder. "FEops has identified a rapidly expanding patient population undergoing transcatheter device procedures who would benefit considerably from its patient-focused procedure-planning approach," added Rob Michiels, Chairman of FEops, "and the inclusion of Tom Fleming to our team is a tremendous endorsement of the FEops technology platform. Given his hands-on operational and business-development achievements in the percutaneous valve replacement sectors, along with his extensive experience in the cardiovascular device industry overall, Tom will be of great value to FEops' evolving strategic direction." "The future of Medical Device innovation will continue to evolve into treating more complex patients, and FEops' computational modeling and simulation capabilities have the opportunity to lead in faster product development and clinical cycles with better patient outcomes," said Tom Fleming. FEops elects Tom Fleming to its board of directors

Read More
http://www.guidedsolutions.co.uk/news/blog/2015/07/27/boston-scientific-announces-ce-mark-and-fda-clearance-for-safari2-pre-shaped-guidewire/

"The Safari2 Guidewire reflects our dedication and our commitment to meaningful innovation in the treatment of structural heart disorders," said Tom Fleming, vice president and general manager, Structural Heart, Boston Scientific.

Read More
http://www.hospimedica.com/surgical_techniques/articles/294759861/preshaped_guidewire_sized_for_smaller_ventricles.html

"The Safari2 Guidewire reflects our dedication and our commitment to meaningful innovation in the treatment of structural heart disorders," said Tom Fleming, vice president and general manager of the structural heart division at Boston Scientific.

Read More

Browse ZoomInfo’s Directories